Prevalence of co-morbidities in a specialist weight management programme prior to bariatric surgery

Authors

  • Daniel Fountain Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, United Kingdom
  • Mohammed Al Kharaiji Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, United Kingdom
  • Sherif Awad Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, United Kingdom East Midlands Bariatric Metabolic Institute, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom East Midlands Bariatric Metabolic Institute, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom
  • David Hughes East Midlands Bariatric Metabolic Institute, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom
  • Iskandar Idris Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, United Kingdom East Midlands Bariatric Metabolic Institute, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom

DOI:

https://doi.org/10.15277/bjd.2019.205

Keywords:

Tier 3 service, bariatric surgery, multidisciplinary, obesity-related co-morbidities

Abstract

Objective: There is limited evidence on the prevalence of patients’ obesity-related co-morbidities and the effectiveness of specialist multidisciplinary weight management (Tier 3) programmes prior to bariatric surgery. We therefore evaluate and report the prevalence of co-morbidities in patients attending a Tier 3 service within the National Health Service.

Methods: This was a prospective observational study of consecutive patients who attended the Tier 3 service at the East Midlands Bariatric Metabolic Institute throughout 2017.

Results: 430 patients attended the service over the study observation period. Twelve patients (2.8%) were excluded from our analysis due to incomplete data. 70.8% of patients were women, mean age at baseline was 46.4 years, mean±SD weight and body mass index at baseline were 137.8±29.2 kg and 48.0±8.6 kg/m2, respectively. The most common co-morbidities recorded at baseline were type 2 diabetes mellitus (31.1%), hypertension (31.1%), depression (26.1%), obstructive sleep apnoea (23.2%) and osteoarthritis (15.6%). Significant weight loss was observed at the 3-month and 6-month follow-up points, but not at the 9- or 12-month follow-up points. 22.5% of patients achieved weight loss of ≥5%.

Conclusion: The prevalence of co-morbidities within this Tier 3 service was high. While specialised weight management services may achieve moderate weight loss through a multidisciplinary intervention, future evaluation of clinical outcomes of specialist weight services should also include co-morbidity outcomes.

References

World Health Organization. Controlling the Global Obesity Epidemic. 2017. Available at: http://www.who.int/nutrition/topics/obesity/en/ (accessed 4 Dec 2017).

NHS Digital. Statistics on Obesity, Physical Activity and Diet. 2017. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/613532/obes-phys-acti-diet-eng-2017-rep.pdf.

Field AE, Byers T, Hunter DJ, et al. Weight cycling, weight gain, and risk of hypertension in women. Am J Epidemiol 1999;150:573–9. https://doi.org/10.1093/oxfordjournals.aje.a010055

Maclure KM, Hayes KC, Colditz GA, et al. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321:563–9. https://doi.org/10.1056/NEJM198908313210902

Hartz AJ, Fischer ME, Bril G, et al. The association of obesity with joint pain and osteoarthritis in the HANES data. J Chronic Dis 1986;39:311–19. https://doi.org/10.1016/0021-9681(86)90053-6

Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968–77. https://doi.org/10.1161/01.CIR.67.5.968

Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705–11. https://doi.org/10.1001/archinte.1994.00420150073007

Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811–16. https://doi.org/10.1016/0002-9343(79)90740-X

Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011;34:1481–6. https://doi.org/10.2337/dc10-2415

NHS Commissioning Board Clinical Reference Group for Severe and Complex Obesity. Clinical Commissioning Policy: Complex and Specialised Obesity Surgery. 2013. Available at: https://www.england.nhs.uk/wp-content/uploads/2016/05/appndx-6-policy-sev-comp-obesity-pdf.pdf

Jennings A, Hughes CA, Kumaravel B, et al. Evaluation of a multidisciplinary Tier 3 weight management service for adults with morbid obesity, or obesity and comorbidities, based in primary care. Clin Obes 2014;4:254–66. https://doi.org/10.1111/cob.12066

Public Health England. Standard Evaluation Framework for Weight Management Interventions. London, 2018. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/685545/SEF_weight_management_interventions.pdf

Magkos F, Fraterrigo G, Yoshino J, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 2016;23:591–601. https://doi.org/10.1016/j.cmet.2016.02.005.

Logue J, Allardice G, Gillies M, Forde L, Morrison DS. Outcomes of a specialist weight management programme in the UK National Health Service: prospective study of 1838 patients. BMJ Open 2014;4:e003747. https://doi.org/10.1136/bmjopen-2013-003747

Kamga-Ngandé CN, Carpentier AC, Nadeau-Marcotte F, et al. Effectiveness of a multidisciplinary program for management of obesity: the Unité d’Enseignement, de Traitement et de Recherche sur l’Obésité (UETRO) database study. Metab Syndr Relat Disord 2009;7:297–304. https://doi.org/10.1089/met.2008.0063

Dixon KJ, Shcherba S, Kipping RR. Weight loss from three commercial providers of NHS primary care slimming on referral in North Somerset: service evaluation. J Public Health (Oxf) 2012;34:555–6. https://doi.org/10.1093/pubmed/fds034

Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. BMJ 2011;343:d6500. https://doi.org/10.1136/bmj.d6500

Gorber CS, Tremblay M, Moher D, Gorber B. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 2007;8:307–26. https://doi.org/10.1111/j.1467-789X.2007.00347.x

Office for National Statistics. Ethnic Groups - East Midlands. London. 2012. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/censusoutputareaestimatesintheeastmidlandsregionofengland

Morrison DS, Boyle S, Morrison C, Allardice G, Greenlaw N, Forde L. Evaluation of the first phase of a specialist weight management programme in the UK National Health Service: prospective cohort study. Public Health Nutr 2012;15:28–38. https://doi.org/10.1017/S1368980011001625

Senior L, Carter D, Capehorn M. Service evaluation of the Rotherham Institute for Obesity and comparison of 2010 and 2011 data. Obes Facts 2013;6(Suppl. 1):116.

Public Health England. Adult Obesity and Type 2 Diabetes. London, 2014. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/338934/Adult_obesity_and_type_2_diabetes_.pdf

NICE. Obesity identification, assessment and management. London, 2014. Available at: https://www.nice.org.uk/guidance/cg189

Downloads

Published

2019-06-27

Issue

Section

Original Research

Most read articles by the same author(s)